Clinical trial
Preventing Depression Recurrence in Diabetes
NCT00374426 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00374426 |
|---|---|
| Title | Preventing Depression Recurrence in Diabetes |
| Official title | Preventing Depression Recurrence in Diabetes |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression, Diabetes |
| Intervention type | Drug |
| Interventions | sertraline |
| Enrollment | 262 |
| Start date | Mar 1, 1998 |
| Completion | Oct 1, 2004 |
| First posted | Sep 11, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: